IL1RN and acute myeloid leukemia: Further work is required to validate this intriguing hypothesis, but if it holds true it could explain the association of low IL-1RN both with myeloproliferation at early or mild stages of disease and with a more primitive state and poor survival in AML patients at diagnose or relapse who are experiencing late or aggressive transformation events.